Pilgrim's Pride (PPC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting is called to approve an amendment to the Amended and Restated Certificate of Incorporation, with no other matters on the agenda.
The amendment aims to enable tax consolidation with JBS USA, providing potential tax and administrative benefits to all shareholders.
The Board, including all Equity Directors, unanimously recommends voting in favor of the amendment.
The JBS Stockholder, holding a majority of shares, is expected to approve the proposal.
Voting matters and shareholder proposals
The sole proposal is to amend the Certificate of Incorporation to adjust board composition and enable tax consolidation.
Shareholders may vote for, against, or abstain; abstentions and broker non-votes count as votes against.
The Board recommends a vote FOR the amendment.
Procedures for submitting shareholder proposals for the 2025 annual meeting are outlined, with deadlines and requirements specified.
Board of directors and corporate governance
The amendment increases the board size to ten when JBS holds 80%+ of shares, with eight JBS Directors and two Equity Directors.
At least two JBS Directors must be independent and financially literate if JBS holds at least 50% of shares.
The amendment removes the obsolete Founder Director role.
Equity Directors retain approval rights over certain key governance actions, protecting minority investors.
Latest events from Pilgrim's Pride
- 2025 net revenues hit $18.5B, adjusted EBITDA $2.3B, with strong U.S./Europe and $2B returned.PPC
Q4 202512 Feb 2026 - Q2 2024 net income and margins surged on strong sales, cost controls, and global demand.PPC
Q2 20242 Feb 2026 - Q3 net sales up 5.2% to $4.6B, adjusted EBITDA margin doubled to 14.4% on strong U.S. and EU results.PPC
Q3 202417 Jan 2026 - Record profitability and margin expansion achieved through operational excellence and branded growth.PPC
Q4 20248 Jan 2026 - Q1 2025 net sales rose 2.3% to $4.5B, with adjusted EBITDA margin at 12% and a $1.5B dividend paid.PPC
Q1 202525 Dec 2025 - 2024 results highlight growth, sustainability, and key governance votes at the annual meeting.PPC
Proxy Filing1 Dec 2025 - Vote sought on amending the charter to enable tax consolidation and adjust board composition.PPC
Proxy Filing1 Dec 2025 - Shareholders will vote on a board structure change to enable tax consolidation with JBS USA.PPC
Proxy Filing1 Dec 2025 - Q2 2025 saw 4.3% sales growth, strong margins, and a $500M special dividend amid robust demand.PPC
Q2 20255 Nov 2025